Xofluza ingredients. The White House announced it has s...
Xofluza ingredients. The White House announced it has signed nine new agreements with pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi to offer medications through TrumpRx at discounted rates. Dec 28, 2025 · The inactive ingredients of XOFLUZA tablets are: croscarmellose sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, povidone K25, sodium stearyl fumarate, talc, and titanium dioxide. Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription flu medicine that attacks the flu virus at its source. As a treatment, Xofluza is only used for uncomplicated flu (flu without serious effects that may require hospital care). Learn about the side effects of Xofluza (baloxavir marboxil), from common to rare, for consumers and healthcare professionals. Xofluza is a human prescription drug by Genentech, Inc. Tamiflu® (oseltamivir phosphate) is an antiviral medicine for treatment of flu in people 2 weeks of age and older and for prevention of flu in people 1 year of age and older. Xofluza 40 mg film coated tablets - Summary of Product Characteristics (SmPC) by Roche Products Limited XOFLUZA is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. Find out what XOFLUZA is made of, from its active ingredient baloxavir marboxil to the inactive components in both tablet and oral suspension forms. . 1)]. lifecycle. The Trump administration has secured additional deals with pharmaceutical manufacturers, rounding out 2025 by announcing drug pricing agreements with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi Xofluza works by stopping the flu virus from replicating in your body. Serious allergic reactions have included anaphylaxis, angioedema, urticaria and erythema multiforme [see Warnings and Precautions (5. The product is distributed in 2 packages with NDC codes 50242-860-01, 50242-860-86. Serious allergic reactions have included anaphylaxis, angioedema, urticaria, and erythema multiforme. The 40 mg film-coated tablet contains Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription medicine flu treatment that attacks the flu virus at its source. S. XOFLUZA tablets inactive ingredients: croscarmellose sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, povidone K25, sodium stearyl fumarate, talc and titanium dioxide. Genentech, Inc. 40 kg. This medicine will be provided either as tablets or a liquid (oral suspension) that is mixed by a healthcare professional. Xofluza is used to treat flu (influenza) and prevent flu after exposure, in people 12 years of age and older. See full safety for more information. Know what to avoid and what to tell your doctor. Xofluza (Baloxavir Marboxil) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Learn what it is, how it works, FDA-approved uses, dosage, side effects, and cost in 2026. [49734] Active ingredients: Baloxavir marboxil Source: European Medicines Agency (EU) Revision Year: 2025 Publisher: Roche Registration GmbH, Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany XOFLUZA is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. This product may contain inactive ingredients, which can cause allergic reactions or other problems. 1 FDA product labeling for this product includes 1 indications and usage, other, 2 dosage and administration, 3 dosage forms and strengths, 4 See the dosing information for XOFLUZA® (baloxavir marboxil), a single-dose flu medication for influenza, and compare dosing information for XOFLUZA vs. Xofluza should not be taken with products that contain polyvalent cations such as laxatives, antacids or oral supplements containing iron, zinc, selenium, calcium or magnesium. 2. Xofluza is an antiviral medicine containing the active ingredient baloxavir m rboxil. While effective, it can interact with other substances you might be taking, which can influence how well the drug works or increase the risk of side effects. Understanding Xofluza Interactions for Safe Usage Xofluza is a prescription antiviral medication used to treat influenza by inhibiting the virus's replication. If the patient weighs less than 15 kg, XOFLUZA for oral suspension in bottle is the recommended presentation. Before taking baloxavir marboxil, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. XOFLUZA for oral suspension is available in two different presentations: packets (30 mg and 40 mg) and bottles (2 mg/mL). For a complete listing, see Dosage Forms, Strengths, Composition and Packaging. XOFLUZA is supplied as tablets and as granules for oral suspension: XOFLUZA tablets are white to light yellow, film-coated tablets for oral administration. Products that contain polyvalent cations may decrease plasma concentrations of baloxavir. Talk to your pharmacist for more details. The active ingredient in Xofluza is baloxavir marboxil. Learn about Xofluza 80 Mg Dose Pack drug interactions, including supplements, dairy, antacids, and vaccines. Xofluza 80 Mg Dose Pack is a single-dose flu treatment. Experience quick relief with Xofluza, an antiviral that treats and prevents influenza A and B in just one dose. Xofluza contains the active ingredient baloxavir marboxil. Healthcare professionals should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use XOFLUZA (see 14. Apr 16, 2021 · XOFLUZA (baloxavir marboxil) is an antiviral PA endonuclease inhibitor. | Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK Summary of medicine characteristics contains detail information about dosage for adults and children , composition and side effects of medicine Xofluza Xofluza contains the active ingredient baloxavir marboxil. Learn the answers to 6 common FAQs about Xofluza with GoodRx. The active component of XOFLUZA is baloxavir marboxil. North Carolina Board of Pharmacy and North Carolina Medical Board Protocol for Testing and Initiation of Therapy for Suspected Influenza Infection 1-23-2026 North Carolina Board of Pharmacy and North Carolina Medical Board Protocol for Testing and Initiation of Therapy for Suspected Influenza Infection 1-23-2026 XOFLUZA XOFLUZA is is a a fi first-in-class, rst-in-class, single-dose, single-dose, oral oral antiviral antiviral medicine medicine that that blocks blocks an an enzyme enzyme within within the the fl flu u virus, virus, stopping stopping viral viral replication replication early early in in the the infl influenza uenza lifecycle. Xofluza 80 mg film coated tablets - Patient Information Leaflet (PIL) by Roche Products Limited XOFLUZA is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. Who should not take XOFLUZA? Do not take XOFLUZA if you are allergic to baloxavir marboxil or any of the ingredients in XOFLUZA. Xofluza's active ingredient, baloxavir marboxil, is considered a prodrug, defined as an inactive product that develops into its active form once it is processed in the body to reach a therapeutic effect. Stay healthy this flu season! Learn about the difference between a cold, COVID-19, and the flu and why the first 48 hours are critical to fighting the flu with XOFLUZA® (baloxavir marboxil), a one-dose prescription flu medication. : XOFLUZA is an influenza virus polymerase acidic (PA) endonuclease inhibitor indicated for: Treatment of acute uncomplicated influenza in patients 5 years of age and older who have been Get answers to common questions about flu symptoms and how to get prescription flu treatment XOFLUZA® (baloxavir marboxil). Serious allergic reactions have included anaphylaxis, angioedema Learn how single-dose XOFLUZA® (baloxavir marboxil) works differently to stop the flu at its source and view the MoA. Baloxavir marboxil The overall safety profile of XOFLUZA is based on data from 1,943 subjects 12 years of age and older in 4 controlled clinical trials who received XOFLUZA [see Clinical Studies (13)]. Xofluza 80 mg film coated tablets - Summary of Product Characteristics (SmPC) by Roche Products Limited Xofluza (baloxavir marboxil) is a prescription drug that’s used to treat influenza (the flu) in adults and children. XOFLUZA is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. Xofluza is an antiviral medicine for treating and preventing flu in adults and children from 1 year of age. The chemical name of baloxavir marboxil is Xofluza is usually given as a single dose to be taken at one time. Xofluza (baloxavir marboxil) was approved for the following therapeutic use: Xofluza is indicated for the treatment of uncomplicated influenza in patients aged 12 years of age and older who have been symptomatic for no more than 48 hours and who are: otherwise healthy, or at high risk of developing influenza complications. Warnings and precautions Talk to your doctor or pharmacist before taking Xofluza. XOFLUZA Film-coated tablet Ref. Before using this medication, tell your doctor or pharmacist your medical The empirical formula of baloxavir marboxil is C 27 H 23 F 2 N 3 O 7 S and the chemical structure is shown below. Serious allergic reactions have included anaphylaxis, angioedema Xofluza is an influenza virus polymerase acidic (PA) endonuclease inhibitor used in the treatment and prevention of influenza (flu). TAMIFLU®. These medicines attack the flu virus and decrease its ability to re Xofluza has no effect on the common cold or other respiratory virus infections. Children and adolescents Do not give this medicine to children below 12 years of XOFLUZA Granules for oral suspension Ref. The safety of XOFLUZA in adult and adolescent subjects is based on data from 3 placebo-controlled trials in which a total of 1,640 subjects received XOFLUZA: 1,334 (81%) subjects were 18 to 64 years of age, 209 (13%) subjects were adults 65 years of age or older, and 97 (6%) subjects were adolescents 12 to 17 years of age. 2 CONTRAINDICATIONS XOFLUZA is contraindicated in patients who are hypersensitive to this drug [7 Warnings and Precautions, Hypersensitivity Reactions] or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container. Both presentations of the for oral suspension are intended for patients who are unable to or have difficulty swallowing tablets, or those who require enteral Since our last update, the Trump administration has continued to pressure pharmaceutical manufacturers to reduce U. 1 Clinical Trials by Indication). Learn about dosage, cost, and more. The NDC Packaged Code 50242-583-01 is assigned to a package of 1 bottle, glass in 1 carton / 20 ml in 1 bottle, glass of Xofluza, a human prescription drug labeled by Genentech, Inc. What you need to know before you take Xofluza Do not take Xofluza if: you are allergic to baloxavir marboxil or any of the other ingredients of this medicine (listed in section 6). According to the White House, Boehringer XOFLUZA is contraindicated in patients with a history of hypersensitivity to baloxavir marboxil or any of its ingredients. 5 Pharmacokinetics in Special Populations, Renal impairment). ) Xofluza belongs to a class of drugs called influenza virus PA endonuclease inhibitors. drug costs. It belongs to a group of medicines called CAP endonuclease inh bitors. Kn Xofluza contains the active ingredient baloxavir marboxil. The ingredients in XOFLUZA are: Medicinal ingredients: Baloxavir marboxil Non-medicinal ingredients: croscarmellose sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, povidone, sodium stearyl fumarate, talc, titanium dioxide. Find patient medical information for Xofluza (baloxavir) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings The safety and efficacy of Xofluza has not been studied in patients with renal impairment. Serious allergic reactions have included anaphylaxis, angioedema, urticaria, and erythema multiforme [see Warnings and Precautions (5. A change in dose is not required for patients with renal impairment (see section 3. The inactive ingredients of XOFLUZA are: croscarmellose sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, povidone, sodium stearyl fumarate, talc, and titanium dioxide. (An active ingredient is what makes a drug work. 2. [115516] Active ingredients: Baloxavir marboxil Source: European Medicines Agency (EU) Revision Year: 2025 Publisher: Roche Registration GmbH, Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany The other ingredients are lactose monohydrate (see Section 2 ‘Xofluza contains lactose’), croscarmellose sodium ((E468) (see Section 2 ‘Xofluza contains sodium’)), povidone (K25) (E1201), microcrystalline cellulose (E460), sodium stearyl fumarate in the tablet core, and hypromellose (E464), talc (E553b) and titanium dioxide (E171) in Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U. tjv9, 9wro2, dvg3, yxx0, qzbavc, bwy1iv, w2o0, imiv1, i5fh, dack,